100536 Federal Register / Vol. 89, No. 239 / Thursday, December 12, 2024 / Notices 

2All contract personnel will sign appropriate 

nondisclosure agreements. 

3Electronic Document Information System 

(EDIS): https://edis.usitc.gov. 

treatment. See 19 CFR 201.6. Documents 

for which confidential treatment by the 

Commission is properly sought will be 

treated accordingly. All information, 

including confidential business 

information and documents for which 

confidential treatment is properly 

sought, submitted to the Commission for 

purposes of this Investigation may be 

disclosed to and used: (i) by the 

Commission, its employees and Offices, 

and contract personnel (a) for 

developing or maintaining the records 

of this or a related proceeding, or (b) in 

internal investigations, audits, reviews, 

and evaluations relating to the 

programs, personnel, and operations of 

the Commission including under 5 

U.S.C. Appendix 3; or (ii) by U.S. 

government employees and contract 

personnel,2 solely for cybersecurity 

purposes. All nonconfidential written 

submissions will be available for public 

inspection at the Office of the Secretary 

and on EDIS.3

This action is taken under the 

authority of section 337 of the Tariff Act 

of 1930, as amended (19 U.S.C. 1337), 

and of §§ 201.10 and 210.8(c) of the 

Commission’s Rules of Practice and 

Procedure (19 CFR 201.10, 210.8(c)). 

By order of the Commission. 

Issued: December 6, 2024. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2024–29185 Filed 12–11–24; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

[OMB Number 1117–0014] 

Agency Information Collection 

Activities; Proposed eCollection 

eComments Requested; Revision of a 

Previously Approved Collection; 

Application for Registration and 

Application for Registration Renewal; 

DEA Forms 224, 224A 

AGENCY: Drug Enforcement 

Administration, Department of Justice. 

ACTION: 30-Day Notice. 

SUMMARY: The Department of Justice 

(DOJ), Drug Enforcement 

Administration (DEA), will be 

submitting the following information 

collection request to the Office of 

Management and Budget (OMB) for 

review and approval in accordance with 

the Paperwork Reduction Act of 1995. 

This proposed information collection 

was previously published in the Federal 

Register on October 7, 2024, allowing 

for a 60-day comment period. 

DATES: Comments are encouraged and 

will be accepted for 30 days until 

January 13, 2025. 

FOR FURTHER INFORMATION CONTACT: If 

you have comments especially on the 

estimated public burden or associated 

response time, suggestions, or need a 

copy of the proposed information 

collection instrument with instructions 

or additional information, please 

contact Heather E. Achbach, Regulatory 

Drafting and Policy Support Section, 

Drug Enforcement Administration; 

Mailing Address: 8701 Morrissette 

Drive, Springfield, Virginia 22152; 

Telephone: (571) 776–3882; Email: 

DEA.PRA@dea.gov or 

Heather.E.Achbach@dea.gov. 

SUPPLEMENTARY INFORMATION: Written 

comments and suggestions from the 

public and affected agencies concerning 

the proposed collection of information 

are encouraged. Your comments should 

address one or more of the following 

four points: 

—Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

—Evaluate the accuracy of the agency’s 

estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

—Enhance the quality, utility, and 

clarity of the information to be 

collected; and/or 

—Minimize the burden of the collection 

of information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms 

of information technology, e.g., 

permitting electronic submission of 

responses. 

Written comments and 

recommendations for this information 

collection should be submitted within 

30 days of the publication of this notice 

on the following website 

www.reginfo.gov/public/do/PRAMain. 

Find this particular information 

collection by selecting ‘‘Currently under 

30-day Review—Open for Public 

Comments’’ or by using the search 

function and entering either the title of 

the information collection or the OMB 

Control Number 1117–0014. This 

information collection request may be 

viewed at www.reginfo.gov. Follow the 

instructions to view Department of 

Justice, information collections 

currently under review by OMB. 

DOJ seeks PRA authorization for this 

information collection for three (3) 

years. OMB authorization for an ICR 

cannot be for more than three (3) years 

without renewal. The DOJ notes that 

information collection requirements 

submitted to the OMB for existing ICRs 

receive a month-to-month extension 

while they undergo review. 

Overview of This Information 

Collection: 

1. Type of Information Collection: 

Revision of a Previously Approved 

Collection. 

2. Title of the Form/Collection: 

Application for Registration and 

Application for Registration Renewal. 

3. Agency form number, if any, and 

the applicable component of the 

Department of Justice sponsoring the 

collection: DEA Forms 224, 224A. The 

applicable component within the 

Department of Justice is the Drug 

Enforcement Administration, Diversion 

Control Division. 

Affected public who will be asked or 

required to respond, as well as a brief 

abstract: 

Affected public (Primary): Business or 

other for-profit. 

Affected public (Other): Not-for-profit 

institutions; Federal, State, Local, and 

tribal governments. 

Abstract: The Controlled Substances 

Act (CSA) (21 U.S.C. 801–971) requires 

all persons that manufacture, distribute, 

dispense, conduct research with, 

import, or export any controlled 

substance to obtain a registration issued 

by the Attorney General. DEA would be 

revising the proposed information 

collection instruments as statutorily 

mandated by the Protecting Patient 

Access to Emergency Medications Act of 

2017. DEA would be creating a new 

business activity and adding it to forms 

DEA–224 and DEA–224A to allow 

Emergency Medical Services agencies to 

register as such, if authorized by state 

law. This new business activity would 

allow EMS agencies to obtain a DEA 

registration that will permit EMS 

agencies to deliver controlled 

substances to their designated locations 

without obtaining a separate registration 

as a Distributor. This registration would 

allow EMS personnel to administer 

controlled substances outside the 

physical presence of a medical director 

or authorizing medical professional in 

the course of providing emergency 

medical services. Upon issuance of an 

EMS agency registration, the EMS 

agency should use the online system to 

identify all of the locations it intends to 

designate under the EMS agencies’ DEA 


ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 89, No. 239 / Thursday, December 12, 2024 / Notices 100537 

registration. This proposed collection 

would also allow EMS agencies to 

choose the option of a single registration 

in each state where the EMS agency 

operates. If the agency operates EMS 

facilities in multiple states, the agency 

must have a separate registration in each 

state where the agency operates. 

4. Obligation to Respond: Required to 

Obtain or Retain Benefits. 

5. Total Estimated Number of 

Respondents: 670,481. 

6. Estimated Time per Respondent: 

0.203029 hours. 

7. Frequency: 1 per year. 

8. Total Estimated Annual Time 

Burden: 136,366 hours. 

9. Total Estimated Annual Other 

Costs Burden: $0. 

If additional information is required, 

contact: Darwin Arceo, Department 

Clearance Officer, Policy and Planning 

Staff, Justice Management Division, 

United States Department of Justice, 

Two Constitution Square, 145 N Street 

NE, 4W–218 Washington, DC 20530. 

Dated: December 6, 2024. 

Darwin Arceo, 

Department Clearance Officer for PRA, U.S. 

Department of Justice. 

[FR Doc. 2024–29122 Filed 12–11–24; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

[OMB Number 1117–0060] 

Agency Information Collection 

Activities; Proposed eCollection 

eComments Requested; New 

Information Collection Request; 

Emergency Medical Services 

Recordkeeping and Notice 

Requirements 

AGENCY: Drug Enforcement 

Administration, Department of Justice. 

ACTION: 30-Day notice. 

SUMMARY: The Department of Justice 

(DOJ), Drug Enforcement 

Administration (DEA), will be 

submitting the following information 

collection request to the Office of 

Management and Budget (OMB) for 

review and approval in accordance with 

the Paperwork Reduction Act of 1995. 

DATES: Comments are encouraged and 

will be accepted for 30 days until 

January 13, 2025. 

FOR FURTHER INFORMATION CONTACT: If 

you have comments especially on the 

estimated public burden or associated 

response time, suggestions, or need a 

copy of the proposed information 

collection instrument with instructions 

or additional information, please 

contact Heather E. Achbach, Regulatory 

Drafting and Policy Support Section, 

Drug Enforcement Administration; 

Mailing Address: 8701 Morrissette 

Drive, Springfield, Virginia 22152; 

Telephone: (571) 776–3882; Email: 

DEA.PRA@dea.gov or 

Heather.E.Achbach@dea.gov. 

SUPPLEMENTARY INFORMATION: This 

proposed information collection was 

previously published in the Federal 

Register on October 7, 2024, at 89 FR 

81110, allowing for a 60-day comment 

period. 

Written comments and suggestions 

from the public and affected agencies 

concerning the proposed collection of 

information are encouraged. Your 

comments should address one or more 

of the following four points: 

—Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

—Evaluate the accuracy of the agency’s 

estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

—Enhance the quality, utility, and 

clarity of the information to be 

collected; and/or 

—Minimize the burden of the collection 

of information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms 

of information technology, e.g., 

permitting electronic submission of 

responses. 

Written comments and 

recommendations for this information 

collection should be submitted within 

30 days of the publication of this notice 

on the following website 

www.reginfo.gov/public/do/PRAMain. 

Find this particular information 

collection by selecting ‘‘Currently under 

30-day Review—Open for Public 

Comments’’ or by using the search 

function and entering either the title of 

the information collection or the OMB 

Control Number 1117–0060. This 

information collection request may be 

viewed at www.reginfo.gov. Follow the 

instructions to view Department of 

Justice, information collections 

currently under review by OMB. 

DOJ seeks PRA authorization for this 

information collection for three (3) 

years. OMB authorization for an ICR 

cannot be for more than three (3) years 

without renewal. The DOJ notes that 

information collection requirements 

submitted to the OMB for existing ICRs 

receive a month-to-month extension 

while they undergo review. 

Overview of This Information 

Collection 

1. Type of Information Collection: 

New Information Collection. 

2. Title of the Form/Collection: 

Emergency Medical Services 

Recordkeeping and Notice 

Requirements. 

3. Agency form number, if any, and 

the applicable component of the 

Department of Justice sponsoring the 

collection: No form number is 

associated with this collection. The 

applicable component within the 

Department of Justice is the Drug 

Enforcement Administration, Diversion 

Control Division. 

4. Affected public who will be asked 

or required to respond, as well as a brief 

abstract: Affected public (Primary): 

Business or other for-profit. 

Affected public (Other): Not-for-profit 

institutions; Federal, State, Local, and 

tribal governments. 

Abstract: The Controlled Substances 

Act (CSA) (21 U.S.C. 801–971) requires 

all persons who handle controlled 

substances to obtain a registration from 

the Attorney General. 21 U.S.C. 822, 

823, 831, 957, and 958. The ‘‘Protecting 

Patient Access to Emergency 

Medications Act of 2017,’’ (hereafter the 

‘‘Act’’) which became law on November 

17, 2017, amended the Controlled 

Substances Act to allow for a new 

registration category for emergency 

medical services agencies that handle 

controlled substances. It also 

established standards for registering 

emergency medical services agencies, 

and set forth new requirements for 

delivery, storage, and recordkeeping 

related to their handling of controlled 

substances. 

With this proposed collection, DEA is 

proposing recordkeeping regulations for 

EMS agencies to incorporate the Act’s 

CSA amendments regarding 

recordkeeping, and to ensure an 

accurate accounting of the controlled 

substances outside the two-registrant 

integrity system. 

The Act require EMS agencies to 

maintain records of the EMS personnel 

whose State license or certification gives 

them the ability to administer controlled 

substances, in compliance with their 

State laws. Under 21 U.S.C 827(b), 

controlled substance records for all DEA 

registrants are required to be maintained 

for at least two years from the date of 

such inventory or records. Following 

the Act, 21 U.S.C. 823(k)(9)(B)(ii), DEA 

would require that records be 

maintained, whether electronically or 

otherwise, at each registered and 


ddrumheller on DSK120RN23PROD with NOTICES1